August 15, 2024
Cort Johnson
Study Finds Fatigued ME/CFS Brains Unable to Adapt to Cognitive Stress
healthrising.org/blog/2024/08/15/chronic-fatigue-syndrome-brain-cognitive-stressor/
The GIST
- BOLD MRIs measure blood oxygen levels (energy production) across the brain and what could be more telling than that? Our brains are never always turned on – that would take too much energy. Instead, when a part of the brain is needed – say, during cognitive activity – the mitochondria in that part of the brain take up more oxygen in the blood.
- In a process called “neurovascular coupling” our brains quickly and efficiently transport blood to the active region. How well they can do this not only determines how well tasks are carried out but also plays an important role in the “energy economics” of the brain. Sluggish blood flows result in the brain working overhard to carry out tasks resulting in fatigue.
- This study gave ME/CFS patients and healthy controls two cognitive tests and assessed which parts of the brain reacted; i.e. which became more active. They wanted to see, if, as past studies have found, people with ME/CFS need to use more of their brains to complete the task – and to see if their brains adapted to the task.
- It turns out that when healthy people do the same task twice their brains use less energy the second time around – they’ve adapted to the task.
- The study found partial evidence that people with ME/CFS used more of their brains than healthy controls to complete the task. The major finding, though, was that their brains did not adapt – in what seemed to signal that postexertional malaise was present – their brains used more energy not less to complete the second task. Somehow doing the task the first time around had made things worse.
- The authors proposed an inadequate activation of a calcium signaling pathway that increases blood flows to distinct parts of the brain was present and noted that several Australian studies have found problems with calcium mobilization in TRPM3 ion channels in natural killer cells in ME/CFS.
- They didn’t mention it but the finding also appears to fit well with Wirth and Scheibenbogen’s hypothesis regarding calcium mobilization problems in the mitochondria and blood vessels. They believe that the inability of the Na+/K+-ATPase enzyme to remove sodium from ME/CFS cells causes the sodium-calcium exchanger (NCX) to import, rather than remove, calcium from the cells. The calcium buildup that results then impacts mitochondrial functioning and the blood vessels.
- Wirth and Lohn recently proposed that dysfunctional TRPM3 ion channels are wreaking havoc not just in immune cells but in cells across the body. They believe further investigations of this ion channel are “crucial” to understanding ME/CFS. (A blog is coming up.)
- The authors of the present study did not mention energy production. One wonders, though, if the exertion of the first cognitive test might have dampened energy production in the same way that physical exertion does.
- If the authors are correct then cognitive stress at least temporarily impairs the ability of the brain to speed resources (in the form of oxygen in the blood) to parts of the brain that need it – producing fatigue. (That sounds like postexertional malaise of the brain to me.) This group has been engaged in a large study (n=288 (!)) examining neurovascular coupling in ME/CFS from different angles.We should learn much more about that soon.
11 August 2024
Van Tin, H.; Rethi, L.; Higa, S.; Kao, Y.-H.; Chen, Y.-J.
Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling.
Cells 2024, 13, 1331.
https://doi.org/10.3390/cells13161331
Abstract:
Background: The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial to viral entry and can cause cardiac injuries. Toll-like receptor 4 (TLR4) and NOD-, LPR-, and pyrin-domain-containing 3 (NLRP3) inflammasome are critical immune system components implicated in cardiac fibrosis. The spike proteins activate NLRP3 inflammasome through TLR4 or angiotensin-converting enzyme 2 (ACE2) receptors, damaging various organs. However, the role of spike proteins in cardiac fibrosis in humans and the interactions of spike proteins with NLRP3 inflammasomes and TLR4 remain poorly understood.
Methods: We utilized scratch assays, Western blotting, and immunofluorescence to evaluate the migration, fibrosis signaling, mitochondrial calcium levels, reactive oxygen species (ROS) production, and cell morphology of cultured human cardiac fibroblasts (CFs) treated with spike (S1) proteins for 24 h with or without an anti-ACE2 neutralizing antibody, a TLR4 blocker, or an NLRP3 inhibitor.
Results: S1 protein enhanced CFs migration and the expressions of collagen 1, α-smooth muscle actin, transforming growth factor β1 (TGF-β1), phosphorylated SMAD2/3, interleukin 1β (IL-1β), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). S1 increased ROS production but did not affect mitochondrial calcium content and cell morphology. Treatment with an anti-ACE2 neutralizing antibody attenuated the effects of S1 on collagen 1 and TGF-β1 expressions. Moreover, NLRP3 (MCC950) and NF-kB inhibitors, but not the TLR4 inhibitor TAK-242, prevented the S1-enhanced CFs migration and overexpression of collagen 1, TGF-β1, and IL-1β.
Conclusion: S1 activates human CFs by priming NLRP3 inflammasomes through NF-κB signaling in an ACE2-dependent manner.
Keywords: angiotensin-converting enzyme 2; cardiac fibroblasts; NLRP3 inflammasome; spike protein
02 August 2024
Arlt Friederike A. , Breuer Ameli , Trampenau Elli , Boesl Fabian , Kirchner Marieluise , Mertins Philipp , Sánchez-Sendín Elisa , Nasouti Mahoor , Mayrhofer Marie , Blüthner Martin , Endres Matthias , Prüss Harald , Franke Christiana
High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome
Front. Immunol., Sec. Vaccines and Molecular Therapeutics, 2024, Vol. 15
https://doi.org/10.3389/fimmu.2024.1404800
Abstract:
Background: Patients suffering from neurological symptoms after COVID-19 vaccination (post-COVID-19 vaccination syndrome (PCVS)) have imposed an increasing challenge on medical practice, as diagnostic precision and therapeutic options are lacking. Underlying autoimmune dysfunctions, including autoantibodies, have been discussed in neurological disorders after SARS-CoV-2 infection and vaccination. Here, we describe the frequency and targets of autoantibodies against peripheral nervous system tissues in PCVS.
Methods: Sera from 50 PCVS patients with peripheral neurological symptoms after COVID-19 vaccination and 35 vaccinated healthy controls were used in this study. IgG autoreactivity was measured via indirect immunofluorescence assays on mouse sciatic nerve teased fibers. The frequencies of autoantibodies were compared between groups using Fisher’s exact test. Serum anti-ganglioside antibodies were measured in ganglioside blots. Autoantibody target identification was performed using immunoprecipitation coupled to mass spectrometry. Subsequent target confirmation was conducted via cell-based assays and ELISA.
Results: Compared with controls, PCVS patients had a significantly greater frequency of autoantibodies against peripheral nervous system structures (9/50(18%) vs 1/35(3%); p=0.04). Autoantibodies bound to paranodes (n=5), axons (n=4), Schmidt-Lanterman incisures (n=2) and Schwann cell nuclei (n=1). Conversely, antibodies against gangliosides were absent in PCVS patients. Target identification and subsequent confirmation revealed various subunits of neurofilaments as well as DFS-70 as autoantibody epitopes.
Conclusion: Our data suggest that autoantibodies against nervous system tissue could be relevant in PCVS patients. Autoantibodies against neurofilaments and cell nuclei with so far non-established links to this disease spectrum should be further elucidated to determine their biomarker potential.